Go Pro

Madrigal Pharmaceuticals (MDGL) Short Interest Ratio & Short Volume

Madrigal Pharmaceuticals logo
$497.44 -2.27 (-0.45%)
As of 03:51 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Madrigal Pharmaceuticals Short Interest Overview

As of September 15, 2026, Madrigal Pharmaceuticals (MDGL) had a short interest of 2.25 million shares sold short, representing 11.84% of the public float. This marks a 0.62% increase in short interest since the prior report. The short interest ratio (days to cover) is 11.4, meaning it would take 11.4 days of the average trading volume of 331,651 shares to cover all short positions.

Current Short Interest
2,254,423 shares
Previous Short Interest
2,240,575 shares
Change Vs. Previous Month
0.62%
Dollar Volume Sold Short
$1.18 billion
Short Interest Ratio
11.4 Days to Cover
Last Record Date
September 15, 2026
Outstanding Shares
23,100,000 shares
Short Percent of Float
11.84%
Today's Trading Volume
221,342 shares
Average Trading Volume
331,651 shares
Today's Volume Vs. Average
67%
Short Selling Madrigal Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

MDGL Short Interest Over Time

MDGL Days to Cover Over Time

MDGL Percentage of Float Shorted Over Time

Madrigal Pharmaceuticals Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/20262,254,423 shares $1.18 billion +0.6%11.8%11.42 $523.26
8/31/20262,240,575 shares $1.21 billion +10.6%11.8%9.46 $540.03
8/14/20262,025,404 shares $1.03 billion +3.0%10.6%6.05 $507.56
7/31/20261,965,849 shares $918.68 million -4.7%10.3%4.84 $467.32
7/15/20262,062,862 shares $1.14 billion -41.5%10.9%6.94 $550.25
6/30/20263,526,539 shares $1.89 billion -6.7%18.6%6.2 $536.95
6/15/20263,780,568 shares $1.89 billion -1.1%19.9%14.32 $499.76
5/29/20263,823,127 shares $1.90 billion -1.9%20.1%14.08 $497.27
5/15/20263,897,454 shares $2.04 billion +1.1%20.5%12.33 $523.69
4/30/20263,854,441 shares $1.99 billion -4.0%20.3%16.47 $517.39
4/15/20264,012,756 shares $2.08 billion +2.7%21.1%12.69 $518.58
3/31/20263,909,299 shares $2.05 billion -0.5%20.6%9.12 $523.47
3/13/20263,929,986 shares $1.75 billion +5.0%21.8%13.93 $444.83
2/27/20263,742,574 shares $1.62 billion +3.4%20.8%8.16 $432.00
2/13/20263,619,351 shares $1.68 billion -9.1%19.1%11.08 $464.71
1/30/20263,983,413 shares $1.95 billion +3.2%22.3%12.69 $489.31
1/15/20263,858,573 shares $1.91 billion +4.0%21.6%9.77 $495.88
12/31/20253,710,257 shares $2.16 billion -0.2%20.8%13.07 $582.34
12/15/20253,718,220 shares $2.08 billion -0.1%20.9%14.03 $560.55
11/28/20253,721,183 shares $2.22 billion -1.7%20.9%9.96 $597.05
11/14/20253,786,197 shares $2.00 billion +1.4%21.7%7.38 $529.21
10/31/20253,735,127 shares $1.56 billion +1.3%21.4%12.67 $418.90
10/15/20253,690,000 shares $1.60 billion -0.8%21.2%10.4 $433.45
9/30/20253,720,000 shares $1.71 billion -10.1%N/A9.8 $458.66
9/15/20254,140,000 shares $1.76 billion +2.2%N/A10.9 $425.60
8/31/20254,050,000 shares $1.77 billion +6.9%23.2%10.7 $437.85
8/15/20253,790,000 shares $1.40 billion -4.8%N/A10.2 $369.84
7/31/20253,980,000 shares $1.20 billion +5.0%22.8%11.5 $302.51
7/15/20253,790,000 shares $1.18 billion -4.5%N/A11.2 $311.14
6/30/20253,970,000 shares $1.20 billion -4.3%22.8%11.9 $302.64
6/15/20254,150,000 shares $1.23 billion +6.7%23.8%12.6 $295.57
5/31/20253,890,000 shares $1.08 billion -2.8%23.1%11.6 $276.70
5/15/20254,000,000 shares $1.17 billion -2.4%23.8%10.7 $291.82
4/30/20254,100,000 shares $1.37 billion +1.7%N/A11 $333.91
4/15/20254,030,000 shares $1.29 billion +0.8%23.9%10.7 $321.10
3/31/20254,000,000 shares $1.32 billion -2.2%23.8%9.9 $331.23
3/15/20254,090,000 shares $1.42 billion +9.1%24.3%10.1 $348.35
2/28/20253,750,000 shares $1.28 billion -1.3%22.3%9.3 $341.27
2/15/20253,800,000 shares $1.28 billion -4.5%22.6%9.8 $337.20
1/31/20253,980,000 shares $1.33 billion -2.5%N/A9.9 $334.80
How Elon’s Empire Ends (and how to profit) (Ad)

Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg terminal, says a new micro cluster AI technology could render today's data centers, including Elon Musk's Colossus in Tennessee, obsolete for major breakthroughs. These next generation centers use 99 percent less space, electricity and water, yet Chaikin's research shows they could be more than a trillion times more powerful than the top data center on earth today, potentially cutting AI breakthrough timelines from five years to five days.tc pixel

See Chaikin's full research and the company name here
1/15/20254,080,000 shares $1.12 billion -0.7%N/A8.6 $274.41
12/31/20244,110,000 shares $1.27 billion -13.1%N/A9.8 $308.57
12/15/20244,730,000 shares $1.44 billion +10.5%N/A11.2 $304.50
11/30/20244,280,000 shares $1.40 billion -3.4%N/A10.6 $328.19
11/15/20244,430,000 shares $1.28 billion -2.2%N/A11.3 $288.58
10/31/20244,530,000 shares $1.17 billion +11.9%N/A13.1 $259.34
10/15/20244,050,000 shares $875.49 million +4.9%N/A15.1 $216.17
9/30/20243,860,000 shares $819.17 million +3.5%N/A13.8 $212.22
9/15/20243,730,000 shares $901.91 million -0.8%N/A13.5 $241.80
8/31/20243,760,000 shares $929.21 million +0.3%N/A11.5 $247.13
8/15/20243,750,000 shares $916.88 million +1.9%N/A9.5 $244.50
7/31/20243,680,000 shares $1.05 billion -10.5%N/A8.6 $284.66
7/15/20244,110,000 shares $1.15 billion +0.7%N/A9.1 $279.95
6/30/20244,080,000 shares $1.14 billion -7.9%N/A9.1 $280.16
6/15/20244,430,000 shares $1.23 billion -15.3%N/A9.5 $277.59
5/31/20245,230,000 shares $1.24 billion +25.4%N/A9.4 $236.16
5/15/20244,170,000 shares $882.91 million +4.8%N/A8.1 $211.73
4/30/20243,980,000 shares $812.00 million +16.7%N/A6.9 $204.02
4/15/20243,410,000 shares $788.97 million +1.5%N/A5.9 $231.37
3/31/20243,360,000 shares $897.25 million +3.1%N/A6 $267.04
3/15/20243,260,000 shares $881.41 million -5.8%20.2%5.9 $270.37
2/29/20243,460,000 shares $817.25 million +2.1%21.4%7.3 $236.20
2/15/20243,390,000 shares $753.33 million +8.0%21.1%7.6 $222.22
1/31/20243,140,000 shares $680.47 million -5.1%19.5%7.2 $216.71
1/15/20243,310,000 shares $780.50 million +1.9%21.1%8.6 $235.80
12/31/20233,250,000 shares $751.99 million +5.9%20.7%7.9 $231.38
12/15/20233,070,000 shares $727.99 million -11.5%19.5%6.7 $237.13
11/30/20233,470,000 shares $705.45 million +0.3%24.4%7.1 $203.30
11/15/20233,460,000 shares $559.41 million +1.5%24.3%7.7 $161.68
10/31/20233,410,000 shares $448.01 million +13.3%24.7%8.2 $131.38
10/15/20233,010,000 shares $422.51 million +13.6%21.8%7.6 $140.37
9/30/20232,650,000 shares $387.01 million +24.4%19.2%7.4 $146.04
9/15/20232,130,000 shares $374.65 million +8.7%16.5%6.3 $175.89
8/31/20231,960,000 shares $352.80 million +8.3%15.2%6.3 $180.00
8/15/20231,810,000 shares $315.25 million -1.1%14.0%5.7 $174.17
7/31/20231,830,000 shares $375.70 million -3.2%13.8%5.3 $205.30
7/15/20231,890,000 shares $426.71 million +7.4%14.3%5.4 $225.77
6/30/20231,760,000 shares $406.56 million +10.0%13.3%4.7 $231.00
6/15/20231,600,000 shares $408.85 million +10.3%12.1%4.7 $255.53
5/31/20231,450,000 shares $403.69 million +15.1%10.4%3.9 $278.41
5/15/20231,260,000 shares $365.77 million -8.7%9.0%3.1 $290.29
4/30/20231,380,000 shares $430.56 million -6.8%10.0%3.3 $312.00
4/15/20231,480,000 shares $354.89 million +19.4%10.8%3.7 $239.79
3/31/20231,240,000 shares $300.40 million +3.3%9.2%3.1 $242.26
3/15/20231,200,000 shares $286.57 million +16.5%8.7%2.3 $238.81
2/28/20231,030,000 shares $279.14 million +9.2%7.4%1.6 $271.01
2/15/2023942,900 shares $266.14 million 0.0%7.2%1.5 $282.26
1/31/2023943,300 shares $271.91 million -3.3%7.2%1.6 $288.25
1/15/2023975,300 shares $292.57 million -12.9%7.5%1.6 $299.98
12/30/20221,120,000 shares $325.08 million -52.7%9.0%1.9 $290.25
The SEC Just Opened The Floodgates… (Ad)

The SEC removed the 25 year old Pattern Day Trader rule in June 2026, cutting the minimum to open a trading account to just 2,000 dollars. Small cap stocks like ONFO, CURR, RMSG, TMDE and VSME have already posted gains ranging from 140 percent to 482 percent, some in a single day. Tim Bohen, known for flagging Tesla at 37 and Nvidia at 6.93, believes this shift could trigger the next major small cap breakout.tc pixel

See how to spot the next small cap breakout before the crowd
12/15/20222,370,000 shares $149.07 million +9.7%19.1%4.3 $62.90
11/30/20222,160,000 shares $151.44 million +3.9%17.4%7.3 $70.11
11/15/20222,080,000 shares $146.68 million +14.3%16.8%7.9 $70.52
10/31/20221,820,000 shares $128.89 million +17.4%14.7%7.4 $70.82
10/15/20221,550,000 shares $100.27 million +1.3%12.5%6.6 $64.69
9/30/20221,530,000 shares $99.43 million +2.7%12.4%7.2 $64.99
9/15/20221,490,000 shares $103.70 million +1.4%12.1%7.4 $69.60
8/31/20221,470,000 shares $106.02 million -4.6%11.9%7.8 $72.12
8/15/20221,540,000 shares $118.13 million -3.8%12.5%8.6 $76.71
7/31/20221,600,000 shares $100.51 million +3.2%12.9%8.4 $62.82
7/15/20221,550,000 shares $107.24 million -4.3%12.5%8.1 $69.19
6/30/20221,620,000 shares $115.96 million -2.4%13.1%8.1 $71.58
6/15/20221,660,000 shares $112.71 million +3.8%13.4%8.6 $67.90
5/31/20221,600,000 shares $106.22 million -5.3%12.9%8.5 $66.39
5/15/20221,690,000 shares $111.08 million -2.9%13.6%8.8 $65.73
4/30/20221,740,000 shares $121.80 million +1.8%14.0%8.2 $70.00
4/15/20221,710,000 shares $135.89 million -5.5%13.8%7.3 $79.47
3/31/20221,810,000 shares $177.60 million -9.1%14.6%7.8 $98.12
3/15/20221,990,000 shares $179.10 million +0.5%16.0%8.5 $90.00
2/28/20221,980,000 shares $183.84 million -1.5%16.0%8.1 $92.85
2/15/20222,010,000 shares $180.72 million +12.3%16.2%8.4 $89.91
1/31/20221,790,000 shares $103.07 million +19.3%14.4%8.5 $57.58
1/15/20221,500,000 shares $117.68 million +8.7%12.1%9.4 $78.45
12/31/20211,380,000 shares $116.94 million -6.8%11.1%9.6 $84.74
12/15/20211,480,000 shares $110.82 million +7.3%11.9%10.8 $74.88
11/30/20211,380,000 shares $114.14 million +2.2%12.0%12 $82.71
11/15/20211,350,000 shares $122.00 million -3.6%11.8%12.7 $90.37
10/29/20211,400,000 shares $108.85 million +3.7%12.2%13.3 $77.75
10/15/20211,350,000 shares $116.33 million -6.9%12.1%13.5 $86.17

MDGL Short Interest - Frequently Asked Questions

Short interest is the volume of Madrigal Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 2,254,423 shares of MDGL short. 11.84% of Madrigal Pharmaceuticals' shares are currently sold short. Learn More on Madrigal Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MDGL shares currently have a short interest ratio of 11.4. Learn More on Madrigal Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.84% of Madrigal Pharmaceuticals' floating shares are currently sold short.

Madrigal Pharmaceuticals saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 2,254,423 shares, an increase of 0.6% from the previous total of 2,240,575 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

11.84% of Madrigal Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Madrigal Pharmaceuticals: Revolution Medicines, Inc. (4.88%), Alnylam Pharmaceuticals, Inc. (5.42%), Biogen Inc. (3.95%), Roivant Sciences Ltd. (5.49%), Insmed, Inc. (5.05%), Incyte Corporation (5.88%), BioNTech SE Sponsored ADR (1.14%), Genmab A/S Sponsored ADR (0.80%), United Therapeutics Corporation (7.14%), Ascendis Pharma A/S (10.59%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($75.21 billion), Invesco QQQ ($46.31 billion), iShares Russell 2000 ETF ($27.98 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($9.70 billion), Canadian Natural Resources Limited ($9.42 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($8.53 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.79 billion), and Financial Select Sector SPDR Fund ($7.74 billion). View all of the most shorted stocks.

Short selling MDGL is an investing strategy that aims to generate trading profit from Madrigal Pharmaceuticals as its price is falling. MDGL shares are trading down $4.25 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Madrigal Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MDGL, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MDGL, twice per month. The most recent reporting period available is September, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like MDGL:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for NASDAQ:MDGL is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 9/24/2026. FINRA publishes updated short interest twice a month.
From Our Partners